State initiatives on prescription drugs: creating a more functional market.
In response to unrelenting increases in prescription drug spending and use, many states are developing and implementing innovative policy solutions. The Reforming States Group (RSG), a nonpartisan organization of senior executive and legislative leaders from more than forty states and provinces formed in 1992, proposes a series of actions to improve the functioning of this market by introducing more explicit information on quality, effectiveness, and price and by experimental waiving of federal regulations.
D016527:Drug Costs; D004345:Drug Industry; D011307:Drug Prescriptions / Q000191:economics*; D004608:Eligibility Determination / Q000331:legislation & jurisprudence; D018166:Health Care Reform / Q000331:legislation & jurisprudence*; D006297:Health Services Accessibility / Q000191:economics / Q000331:legislation & jurisprudence*; D007857:Leadership; D007880:Legislation, Drug; D008484:Medicaid / Q000331:legislation & jurisprudence*; D013221:State Health Plans / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States